Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
410.53%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 9.42Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information
Ticker
RNACCompany Name
CARTESIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARTESIAN THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RNAC - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 4.21M | 410.53% | $ 1.03M |
| 3/31/2025 | $ 4.23M | 12.39% | $ 34.17M |
| 12/31/2024 | $ 3.59M | 9.22% | $ 38.91M |
| 9/30/2024 | $ 3.18M | 6.63% | $ 47.94M |
| 6/30/2024 | $ 2.87M | 5.3% | $ 54.1M |
| 3/31/2024 | $ 2.67M | 10.31% | $ 25.91M |
| 12/31/2023 | $ 2.6M | 9.99% | $ 26M |
| 9/30/2023 | $ 2.5M | 7.23% | $ 34.53M |
| 6/30/2023 | $ 2.56M | 5.26% | $ 48.69M |
| 3/31/2023 | $ 2.6M | 3.15% | $ 82.72M |
Key Performance Insights, Last 5 Years
- CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 25.27%.
- Over the past 5 years, CARTESIAN THERAPEUTICS INC's average DepAmor % has been 27.09%.
- The median DepAmor % for CARTESIAN THERAPEUTICS INC during this period was 5.8%
- CARTESIAN THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 410.53%.
- The lowest DepAmor % recorded by CARTESIAN THERAPEUTICS INC in the same timeframe 2.03%
CARTESIAN THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for CARTESIAN THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.86M ] / Revenues [ $ 11.3M ]
(=) DepAmor % [ 25.27% ] RNAC - Depreciation and Amortization Margin, Last 5 years
2.03%
Minimum
Jun 30, 2022
410.53%
Maximum
Jun 30, 2025
27.09%
Average
5.8%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.84% with a standard deviation of 5.11%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.51% |
| average | 5.84% |
| median | 4.21% |
| std | 5.11% |